CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis (Q63728112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Peter Garred

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

H O Madsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C V Jensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Jensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

98-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

The CCR5 deletion mutation fails to protect against multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

HLA typing in the United Kingdom multiple sclerosis genome screen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

A full genome search in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

CSF neopterin as marker of disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Genomewide scan of multiple sclerosis in Finnish multiplex families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

CCR5 is characteristic of Th1 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Interleukin-2, soluble interleukin-2-receptor, neopterin,l-tryptophan and ?2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Onset symptoms of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Etiology and pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Indictment of the microglia as the villain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900166-6

7 January 2021

10.1016/S0165-5728(99)00166-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626673%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference